CD86, IL10RA, TNFSF13B, and CMKLR1 suppress effective anti-tumor immunity while simultaneously potentially promoting pro-tumor immune subsets – representing immunosuppressive signaling. This evidence concerns the gene CMKLR1 and neoplasm.